In August, the Bank of England pulled out a “sledgehammer” and fiscal stimulus may be on the cards, but this may not be enough to counter the uncertainty caused by the vote on June 23rd.
Three months have passed since the United Kingdom (UK) held a referendum on its membership of the European Union (EU), in which the majority opted to leave the union. Soon after the referendum, Mark Carney, the Governor of the Bank of England (BoE), hinted that the central bank was likely to take steps to stimulate the economy. This materialised in early August, when the BoE cut rates for the first time since the financial crisis.
Hot Bank Stocks To Buy Right Now: Abeona Therapeutics Inc.(ABEO)
- [By Jim Robertson]
Small and micro cap stocks can obviously be a fickle bunch, but I sure hope all of you participated in Abeona Therapeutics Inc. (ABEO) back when we first put the idea out there in early June. What a tremendous stock this has been for all of us, and it’s not like this happens all of the time.
- [By Jim Robertson]
On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap rare disease stock Abeona Therapeutics Inc (NASDAQ: ABEO):
Abeona Therapeutics is clearly a timing trade – we think today’s something of a blowoff top, marked by a volume surge and the fact that the stock’s already peeling back from its peak; the profit-takers are already going to work. We saw a similar surge on Tuesday, and though that one didn’t end up kick-starting a pullback, it helped set up today’s reversal bar (by virtue of luring in the last of the would-be buyers). There’s just not a lot of room left for more upside.
Hot Bank Stocks To Buy Right Now: North American Energy Partners, Inc.(NOA)
- [By Lisa Levin]
In trading on Tuesday, energy shares slipped by 1.36 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and North American Energy Partners Inc.(USA) (NYSE: NOA), down 6 percent.
Hot Bank Stocks To Buy Right Now: Helen of Troy Limited(HELE)
- [By Teresa Rivas]
Helen of Troy (HELE) is trading lower Friday, after reporting a mixed first quarter.
The personal care products company said it earned $1.27 a share on revenue that rose 0.8% to $347.9 million. Analysts were expecting earnings of $1.17 per share on revenue of $356.1 million. Gross profit margin increased 2.3 percentage points to 43.8%, while cash flow from operations climbed from $37.8 million in the year ago period to $41.7 million.
For the full year, Helen of Troy expects to earn between $5.85 to $6.35 a share on revenue of $1.57 billion to $1.62 billion. Analysts are modeling for earnings of $6.12 a share on revenue of $1.6 billion. However the company also warned that it expects a decline in sales for its nutritional supplement division.
Jefferies Trevor Young reiterated a Buy rating and $114 price target on the stock today:
Despite the 1Q revenue miss and ~30bps (~$4m) expected incremental FX headwinds, management maintained its FY revenue and adjusted EPS guidance (GAAP EPS came down $0.23 on the high and low end due to $6.6m of after tax non-cash asset impairment and patent litigation charges). Embedded in this guidance is the assumption of beauty coming in at the low end of the previous -7% to -12% range, and nutritional declining MSD (vs. flat to LSD positive growth previously). We believe this implies that housewares (MSD positive growth guidance previously) and health & home (LSD positive growth previously) would have to perform incrementally better than prior expectations, which we view as a positive.
The shares are down 3.3% to $99.31 in recent trading.